Breast Cancer Clinical Trial

Automated Method for Breast Cancer Detection

Summary

Participants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance. The FNA will be read by the cytopathologist and analyzed in the breast cancer detection cartridge. All patients will receive standard of care (Ultrasound-guided core needle biopsy and diagnosis). We will also receive FNA collected from 60 patients with palpable lesions in South Africa and analyze them samples in our lab with the same method.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient must be female
Patient must be 18 years of age or older
Patient has been recommended for ultrasound core needle biopsy of a suspicious breast lesion

Exclusion Criteria:

Patients may be excluded for any condition that in the opinion of the investigator may not make it safe to take part (e.g. certain medicines).

Study is for people with:

Breast Cancer

Estimated Enrollment:

116

Study ID:

NCT03863522

Recruitment Status:

Terminated

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Johns Hopkins Hospital Outpatient Center
Baltimore Maryland, 21287, United States
Johns Hopkins Medical Imaging at Green spring Station
Lutherville-Timonium Maryland, 21093, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

116

Study ID:

NCT03863522

Recruitment Status:

Terminated

Sponsor:


Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider